scispace - formally typeset
V

Vijay Kumar Prajapati

Researcher at Central University of Rajasthan

Publications -  117
Citations -  3698

Vijay Kumar Prajapati is an academic researcher from Central University of Rajasthan. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 31, co-authored 93 publications receiving 2754 citations. Previous affiliations of Vijay Kumar Prajapati include Institute of Medical Sciences, Banaras Hindu University & Banaras Hindu University.

Papers
More filters
Journal ArticleDOI

Advances in the Diagnosis of Visceral Leishmaniasis

TL;DR: This work has shown that recombinant antigen rK16, 39-amino acid protein obtained from C terminus of L. donovani immobilized in two different formats, a flow through test (KEFT) or Signal KA, and a lateral flow test (KELF) or Crystal KA had shown higher sensitivity in Indian subcontinent than East Africa and Brazilian VL subjects.
Journal ArticleDOI

Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2

TL;DR: In this paper , an in-silico Bispecific antibody (BsAb) was designed by using KIH (Knobs into Holes) and CrossMAb techniques to prevent heavy chain and light chain mispairings.
Journal ArticleDOI

Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins.

TL;DR: Sarma et al. as mentioned in this paper used immunoinformatics applications to delineate a vaccine candidate possessing multiple B and T cells epitopes by utilizing the SARS-CoV-2 non structural and structural proteins.
Journal ArticleDOI

Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases.

TL;DR: Ibuprofen is a classical nonsteroidal anti-inflammatory drug (NSAID) highly prescribed to reduce acute pain and inflammation under an array of conditions, including rheumatoid arthritis, osteoarthritis, dysmenorrhea, and gout.
Journal ArticleDOI

A rapid method to assess the stage differentiation in Leishmania donovani by flow cytometry.

TL;DR: This study describes a rapid and novel method to assess the morphological stage differentiation in Leishmania donovani by flow cytometry (FCM), and believes that this method is an alternative tool for high reproducibility and reliability in assessment of stage differentiation.